Clinical trials for Waldenström macroglobulinemia
9 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT07387471Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)AbbVie · PI: ABBVIE INC.
- RECRUITINGPhase 2NCT05099471Efficacy of Venetoclax in Combination With Rituximab in Waldenström's MacroglobulinemiaChristian Buske · PI: Christian Buske, Prof. Dr.
- RECRUITINGPhase 2NCT06561347Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WMMassachusetts General Hospital · PI: Andrew Branagan, MD, PhD
- RECRUITINGPhase 2NCT05190705Loncastuximab Tesirine in WMShayna Sarosiek, MD · PI: Shayna Sarosiek, MD
- RECRUITINGNCT05093153Spanish Registry of Patients With IgM Monoclonal GammopathiesFundación Española de Hematología y Hemoterapía
- ACTIVE NOT RECRUITINGPhase 2NCT04624906Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's MacroglobulinemiaSunnybrook Health Sciences Centre · PI: Neil L Berinstein, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04273139Ibrutinib + Venetoclax in Untreated WMDana-Farber Cancer Institute · PI: Jorge J Castillo, MD
- RECRUITINGPHASE2, PHASE3NCT04061512Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's MacroglobulinaemiaUniversity College, London
- ACTIVE NOT RECRUITINGPhase 1NCT01209871Vaccine Therapy in Treating Patients With Lymphoplasmacytic LymphomaM.D. Anderson Cancer Center · PI: Sheeba Thomas